This is part of a larger recall. The most authoritative record is FDA-Drug / D-0082-2027.

FDA-Drug2026-10-26Class IPROCESSING DEFECT

Par Argatroban Injection recalled for particulate matter contamination

METALOTHERPLASTICNationwide distributionDrugs

What this means

Par Pharmaceutical's Argatroban Injection vials have been found to contain small particles of cellulose, polystyrene, polyethylene terephthalate, stainless steel, or stopper material in the solution. This affects specific lot numbers distributed nationwide. The contamination was identified during quality testing.

  • Check if you have Argatroban Injection lot #84193 (expires 10/2026) or lot #92880 (expires 08/2027).
  • Do not use affected vials.
  • Contact your pharmacy or hospital supplier immediately to report and return contaminated vials.
  • Consult your doctor or healthcare provider about alternative anticoagulation therapy if doses were scheduled.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
1944 vials
Manufactured in
870 Parkdale Rd, Rochester, Michigan, United States
Products
Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/ Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Cranbury, NJ 08512, NDC 42023-182-89.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0083-2027

More Paragon 28 recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.